The Revenue for the quarter ended  September 2023 of Rs. 1635.96 millions grew by 11.30 % from Rs. 1469.88 millions.The Net Loss for the quarter ended September 2023 is Rs. -209.56 millions as compared to Net Profit of Rs. 190.37 millions of corresponding quarter ended September 2022A decline of 198.82 millions was observed in the OP in the quarter ended September 2023 from 289.79 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 1635.96 1469.88 11.30 3059.47 2779.94 10.06 6167.34 5201.35 18.57
Other Income 12.59 8.54 47.42 23.61 14.73 60.29 43.20 27.62 56.41
PBIDT 198.82 289.79 -31.39 463.45 525.21 -11.76 1269.82 1079.38 17.64
Interest 7.73 4.49 72.16 12.82 6.31 103.17 24.14 64.07 -62.32
PBDT -126.45 285.30 -144.32 133.09 518.90 -74.35 1245.68 1015.31 22.69
Depreciation 34.03 28.19 20.72 68.28 58.57 16.58 123.42 100.80 22.44
PBT -160.48 257.11 -162.42 64.81 460.33 -85.92 1122.26 914.51 22.72
TAX 49.08 66.74 -26.46 105.77 121.33 -12.82 288.82 195.04 48.08
Deferred Tax 6.54 6.21 5.31 9.85 10.84 -9.13 25.05 27.83 -9.99
PAT -209.56 190.37 -210.08 -40.96 339.00 -112.08 833.44 719.47 15.84
Equity 368.81 364.37 1.22 368.81 364.37 1.22 364.37 364.37 0.00
PBIDTM(%) 12.15 19.72 -38.36 15.15 18.89 -19.82 20.59 20.75 -0.78

Acutaas Chemicals Share Price

1674.80 23.15 (1.40%)
29-Dec-2025 11:16 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1721.90
Dr. Reddys Lab 1263.45
Cipla 1502.25
Zydus Lifesciences 905.45
Lupin 2093.40
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×